WallStSmart
BAX

Baxter International Inc

NYSE: BAX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$17.53
+0.16% today

Updated 2026-06-05

Market cap
$10.87B
P/E ratio
P/S ratio
0.96x
EPS (TTM)
$-1.91
Dividend yield
1.79%
52W range
$16 – $31
Volume
7.3M

Baxter International Inc (BAX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$10.38B$11.26B$12.35B$12.56B$12.84B$13.89B$13.94B$9.41B$10.72B$9.97B$10.16B$10.58B$11.10B$11.36B$11.67B$12.15B$10.06B$10.36B$10.64B$11.24B
Revenue growth (YoY)+8.5%+9.6%+1.7%+2.2%+8.2%+0.3%-32.5%+13.9%-7.0%+2.0%+4.1%+4.9%+2.4%+2.7%+4.1%-17.2%+3.0%+2.7%+5.7%
Cost of revenue$5.64B$5.74B$6.22B$6.04B$6.88B$6.85B$6.80B$5.25B$6.14B$5.82B$6.05B$6.11B$6.34B$6.60B$7.09B$7.43B$6.51B$6.21B$6.65B$7.87B
Gross profit$4.74B$5.52B$6.13B$6.53B$5.96B$7.05B$7.13B$4.16B$4.58B$4.15B$4.12B$4.47B$4.76B$4.76B$4.59B$4.72B$3.55B$4.15B$3.98B$3.38B
Gross margin45.6%49.0%49.6%51.9%46.4%50.7%51.2%44.2%42.7%41.6%40.5%42.3%42.9%41.9%39.3%38.9%35.3%40.1%37.5%30.1%
R&D$614.00M$760.00M$868.00M$917.00M$915.00M$946.00M$1.08B$582.00M$610.00M$603.00M$646.00M$615.00M$654.00M$595.00M$521.00M$531.00M$450.00M$518.00M$590.00M$518.00M
SG&A$2.28B$2.52B$2.70B$2.73B$2.91B$3.92B$3.32B$3.68B$4.03B$3.09B$21.00M$2.63B$2.62B$2.54B$2.47B$2.85B$3.10B$3.94B$2.97B$2.89B
Operating income$1.84B$2.17B$2.56B$2.88B$2.14B$2.95B$2.82B$496.00M$656.00M$449.00M$745.00M$1.29B$1.58B$1.77B$1.62B$1.35B$-2.85B$707.00M$14.00M$-308.00M
Operating margin17.7%19.2%20.8%22.9%16.6%21.2%20.2%5.3%6.1%4.5%7.3%12.2%14.3%15.6%13.8%11.1%-28.3%6.8%0.1%-2.7%
EBITDA$2.42B$2.82B$3.24B$3.49B$2.69B$3.62B$3.66B$1.17B$1.45B$1.33B$5.84B$1.94B$2.48B$1.87B$2.27B$2.19B$-1.76B$1.73B$1.12B$766.00M
EBITDA margin23.3%25.0%26.2%27.8%20.9%26.0%26.3%12.4%13.5%13.4%57.5%18.3%22.4%16.5%19.4%18.0%-17.5%16.7%10.5%6.8%
EBIT$1.84B$2.24B$2.61B$2.85B$2.00B$2.95B$2.95B$530.00M$657.00M$574.00M$5.04B$1.19B$1.71B$1.08B$1.45B$1.32B$-2.83B$750.00M$119.00M$-215.00M
Interest expense$101.00M$124.00M$148.00M$117.00M$115.00M$54.00M$113.00M$155.00M$167.00M$146.00M$89.00M$85.00M$93.00M$111.00M$153.00M$207.00M$413.00M$508.00M$408.00M$290.00M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$1.40B$1.71B$2.01B$2.21B$1.42B$2.22B$2.33B$2.01B$2.50B$968.00M$4.96B$602.00M$1.55B$1.00B$1.10B$1.28B$-2.43B$2.66B$-649.00M$-957.00M
Net income growth (YoY)+22.3%+18.0%+9.5%-35.6%+56.6%+4.6%-13.5%+24.1%-61.2%+412.9%-87.9%+156.8%-35.3%+10.1%+16.5%-289.5%+209.2%-124.4%-47.5%
Profit margin13.5%15.2%16.3%17.6%11.1%16.0%16.7%21.4%23.3%9.7%48.9%5.7%13.9%8.8%9.4%10.6%-24.2%25.6%-6.1%-8.5%

Frequently asked questions

What is Baxter International Inc's revenue?

Baxter International Inc's trailing twelve-month revenue is $11.32B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is BAX?

In its most recent fiscal year, BAX ran a gross margin of 30.05%, an operating margin of -2.74%, and a net margin of -8.51%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does BAX generate?

BAX produced $323.00M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BAX's balance sheet healthy?

BAX holds $1.97B in cash and equivalents against $9.47B in long-term debt, on $6.13B of shareholder equity. That debt is best read against the cash flow the business throws off each year.